Dr. Reddys Labs (RDY) Posts Stronger Q1 EPS of 0.40
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- US stock futures mixed as Apple slides, midterms loom
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts RDY Hot Sheet
Join SI Premium – FREE
Dr. Reddys Labs (NYSE: RDY) reported Q1 EPS of $0.40, versus $0.30 reported last year. Revenue for the quarter came in at $457 million, versus $356 million reported last year.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Xometry, Inc. (XMTR) Tops Q3 EPS by 9c ; Offers Guidance
- Vital Farms (VITL) Misses Q3 EPS by 5c ; Offers Guidance
- Versant Corp. (VSNT) Reports Q3 EPS of $0.34 ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
